Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sun Pharmaceutical Industries Ltd. Share Issue/Capital Change 2021

Apr 10, 2021

59215_rns_2021-04-10_8e64cecd-4d6a-4317-8f6d-2cb7383e66ec.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Sun Pharmaceutical Industries Limited

Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel. : (91-22) 4324 4324 Fax : (91-22) 4324 4343 Website: www.sunpharma.com CIN: L24230GJ1993PLC019050

==> picture [67 x 73] intentionally omitted <==

April 9, 2021

National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051. NSE Code: SUNPHARMA

BSE Limited,

Market Operations Dept. P. J. Towers, Dalal Street, Mumbai - 400 001. Stock Code: 524715

Dear Sirs,

Sub: Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of issue of duplicate share certificates to the following shareholders:

Sr.No. Folio No. Name of the Shareholder(s) New ShareCertificateNo. Share Distinctive Nos. Share Distinctive Nos. No. ofshares
1 R02146 RAMSINHJI RAOLJAYSHREE RAOL 272576 039773562 039779561 6000
2 009864 ROOHI R OOMERBHOYNROOMERBHOOY 272577 035883621 035883800 180

This is for your information and record.

Thanking you,

Yours faithfully,

For Sun Pharmaceutical Industries Limited

Ashok Digitally signed by Indulal Ashok Indulal Bhuta Date: 2021.04.10 Bhuta 13:48:41 +05'30' Ashok Bhuta Sr. GM – Secretarial & Compliance Officer

Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA.

Reaching People. Touching Lives.